MedTrace Logo

Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

NCT06453239 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-06-11

No results posted yet for this study

Summary

To assess the diagnostic significance of serum pro-NT in MASLD and ability to differentiate between early and advanced steatosis.

Conditions

  • Steatosis of Liver

Interventions

DIAGNOSTIC_TEST

Pro-Neurotensin level as a Serum Biomarker

Pro-Neurotensin mediates the development of fatty liver disease. Neurotensin (NT) is a 13-amino acid peptide secreted by the neuroendocrine cells of the small intestine in response to fat ingestion, which facilitates fatty acid absorption through the gut in relation to food lipid content.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Reem Mahmoud, lecturer · Sohag

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2025-07-31
Completion
2025-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06453239 on ClinicalTrials.gov